Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Di Forti

Showing results (21-30 of 197) with videos related to

Pageof 20
Sort By:
Psychiatry Research|May 19, 2017
Effect of continued cannabis use on medication adherence in the first two years following onset of psychosisTabea Schoeler, Natalia Petros, Marta Di Forti, et al.
The Lancet. Psychiatry|July 15, 2017
Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysisTabea Schoeler, Natalia Petros, Marta Di Forti, et al.
JAMA Psychiatry|June 11, 2025
Cannabis Withdrawal and Psychiatric Intensive CareAliyah Malik, Hitesh Shetty, Dominic Oliver, et al.
Brain, Behavior, and Immunity|January 26, 2020
Baseline high levels of complement component 4 predict worse clinical outcome at 1-year follow-up in first-episode psychosisValeria Mondelli, Marta Di Forti, B Paul Morgan, et al.
NPJ Schizophrenia|June 24, 2016
Erratum: Interaction between DRD2 and AKT1 genetic variations on risk of psychosis in cannabis users: a case-control studyMarco Colizzi, Conrad Iyegbe, John Powell, et al.
Frontiers in Psychiatry|December 17, 2020
Early Intervention Services for First Episode of Psychosis in South London and the Maudsley (SLaM): 20 Years of Care and Research for Young PeoplePaolo Fusar-Poli, Serena Lai, Marta Di Forti, et al.
Addiction (Abingdon, England)|November 7, 2020
Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysisTom P Freeman, Sam Craft, Jack Wilson, et al.
Schizophrenia Bulletin|March 27, 2024
Antipsychotic Use and Psychiatric Hospitalization in First-Episode Non-affective Psychosis and Cannabis Use Disorder: A Swedish Nationwide Cohort StudyAlexander Denissoff, Heidi Taipale, Jari Tiihonen, et al.
NPJ Schizophrenia|January 23, 2021
Investigating the effects of genetic risk of schizophrenia on behavioural traitsAdam Socrates, Jessye Maxwell, Kylie P Glanville, et al.
Psychological Medicine|February 4, 2021
Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative reviewRachel Lees, Lindsey A Hines, Deepak Cyril D'Souza, et al.
Pageof 20

Showing results (21-30 of 197) with videos related to

Sort By:
Pageof 20
Psychiatry Research|May 19, 2017
Effect of continued cannabis use on medication adherence in the first two years following onset of psychosisTabea Schoeler, Natalia Petros, Marta Di Forti, et al.
The Lancet. Psychiatry|July 15, 2017
Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysisTabea Schoeler, Natalia Petros, Marta Di Forti, et al.
JAMA Psychiatry|June 11, 2025
Cannabis Withdrawal and Psychiatric Intensive CareAliyah Malik, Hitesh Shetty, Dominic Oliver, et al.
Brain, Behavior, and Immunity|January 26, 2020
Baseline high levels of complement component 4 predict worse clinical outcome at 1-year follow-up in first-episode psychosisValeria Mondelli, Marta Di Forti, B Paul Morgan, et al.
NPJ Schizophrenia|June 24, 2016
Erratum: Interaction between DRD2 and AKT1 genetic variations on risk of psychosis in cannabis users: a case-control studyMarco Colizzi, Conrad Iyegbe, John Powell, et al.
Frontiers in Psychiatry|December 17, 2020
Early Intervention Services for First Episode of Psychosis in South London and the Maudsley (SLaM): 20 Years of Care and Research for Young PeoplePaolo Fusar-Poli, Serena Lai, Marta Di Forti, et al.
Addiction (Abingdon, England)|November 7, 2020
Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysisTom P Freeman, Sam Craft, Jack Wilson, et al.
Schizophrenia Bulletin|March 27, 2024
Antipsychotic Use and Psychiatric Hospitalization in First-Episode Non-affective Psychosis and Cannabis Use Disorder: A Swedish Nationwide Cohort StudyAlexander Denissoff, Heidi Taipale, Jari Tiihonen, et al.
NPJ Schizophrenia|January 23, 2021
Investigating the effects of genetic risk of schizophrenia on behavioural traitsAdam Socrates, Jessye Maxwell, Kylie P Glanville, et al.
Psychological Medicine|February 4, 2021
Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative reviewRachel Lees, Lindsey A Hines, Deepak Cyril D'Souza, et al.
Pageof 20